A Meta-analysis of the Efficacy of Venlafaxine ER 75 to 225  mg/d for the Treatment of MDD.

CONCLUSIONS: Venlafaxine ER 75-225 mg/d effectively reduced symptoms of depression in patients with MDD overall and in patients with either lower (≤23) or higher (>23) HAM-D17 total score at baseline. PMID: 27794623 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research